Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-20CASI3Form 3 Filing by Xuebo ZengMEDIUM
Xuebo Zeng, a director at CASI Pharmaceuticals, Inc., reported the acquisition of derivative securities on March 18, 2026. The filing details three option grants, all of which are fully vested and exercisable. The first option, with an exercise price of $1.93, gives the right to buy 11,231 Ordinary Shares and expires o...
Nano CapBiotechnology